Cambridge Consultants develops Viewi optical to combat glaucoma

By: |
Updated: September 13, 2016 2:44 PM

The Viewi technology performs test at a fraction of the cost, around £20 rather than £20,000 for the clinical device

The Viewi technology performs test at a fraction of the cost, around £20 rather than £20,000 for the clinical device

Innovative technology from product design and development firm Cambridge Consultants could help combat glaucoma, a major global cause of blindness, second only to cataracts. It offers a low-cost, user-friendly way of diagnosing and monitoring the disease, so that early intervention and treatment can help slow its progress.

The Viewi optical concept developed by Cambridge Consultants shows how it could be possible for patients to monitor any effect on their vision in the comfort of their own homes. At the moment, patients typically have an annual optometrist or hospital check-up using a visual field analyser. Flashing lights at varying points of the visual field test sensitivity – with the patient pressing a button each time they see a light. The Viewi technology performs the same test but at a fraction of the cost – around £20 rather than £20,000 for the clinical device.

At the heart of the Viewi concept is the extensive optical expertise of Cambridge Consultants, which has been combined with a smartphone app to reproduce the hospital-based ‘static perimetry’ test. The smartphone is slotted into the light and portable headset, and runs a fast, conventional supra threshold test in less than five minutes per eye. The patient simply presses a button – connected to the headset wirelessly via Bluetooth Smart – each time they see one of the flashing dots.

Human factors considerations were a key element in the design of the Viewi system as it had to be user-friendly for patients with sight problems, many of whom are also elderly. The results of the static perimetry test are displayed in a non-technical, intuitive format on the smartphone – tracking the progression of the disease – and can be shared instantly with the patient’s optician.

“Loss of vision as a result of open-angle glaucoma cannot be recovered – but early diagnosis and treatment can slow the progression of the disease,” said Simon Karger, Head of Surgical and Interventional products, Cambridge Consultants. “But although the current clinical tests work exceptionally well, the system for glaucoma management is overloaded. We’ve used our optical expertise – coupled with our algorithm skills – to show how a simple, affordable, fast glaucoma screening test that patients can do at home is entirely feasible. The Viewi system doesn’t aim to replace the current screening and management system – it’s been designed to augment the clinical tests.”

The innovative Viewi concept has been hailed as an important advance by optics expert Chris Dainty, a professor at University College London Institute of Ophthalmology and Moorfields Eye Hospital.

“The Viewi technology could provide a valuable early warning system for people at risk of developing glaucoma, as well as patients who need to monitor the effects of the disease on their vision,” he said. “It could also make the static perimetry test accessible to more patients in developing countries, where expensive clinical equipment and trained professionals are often in short supply.”

EH News Bureau

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.